“Janus Kinase Inhibitors in Rheumatoid Arthritis-Associated Interstitial Lung Disease: Where Do We Stand and What May Be the Future?”. 2025. Reumatismo, January. https://doi.org/10.4081/reumatismo.2025.1754.